A cross-performance relationship between carr's index and dissolution rate constant: The study of acetaminophen batches

Drug Development and Industrial Pharmacy

Volumn 33, Issue 11, 2007, Pages 1273-1284

  Lee, Tu ^a   Hsu, Fu Bin ^a  

^a NATIONAL CENTRAL UNIVERSITY   (Taiwan)

Author keywords

Acetaminophen; Carr's index; Cross performance relationship; Dissolution rate constant; FT IR microscopic mapping; Power law

Indexed keywords

CRYSTALLIN; PARACETAMOL; POVIDONE;

ANALYTIC METHOD; ARTICLE; CRYSTALLIZATION; DISSOLUTION; DRUG FORMULATION; FLOW KINETICS; INFRARED SPECTROSCOPY; MICROSCOPY; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; VALIDATION PROCESS;

ACETAMINOPHEN; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; PARTICLE SIZE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 36749090071     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701542390     Document Type: Article

References (35)

1. Albertini, B., Cavallari, C., Passerini, N., Voinovich, D., González-Rodríguez, M. L., Magarotto, L., & Rodriguez, L. (2004). Characterization and taste-masking evaluation of acetaminophen granules: comparison between different preparation methods in a high-shear mixer. Eur. J. Pharm. Sci., 21, 295-303.
2. Byrn, S., Morris, K., & Comella, S. (2005). Reducing time to market with a science-based product management strategy. Pharmaceutical Technology, outsourcing resources for the pharmaceutical industry, 46-56.
3. Cao, Q. R., Choi, Y. W., Cui, J. H., & Lee, B. J. (2005). Formulation, release characteristics, and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen. J. Contr. Release, 108, 351-361.
4. Chan, K. L. A., & Kazarian, S. G. (2005). Fourier transform infrared imaging for high-throughput analysis of pharmaceutical formulations. J. Comb. Chem., 7, 185-189.
5. Colley, C. S., Kazarian, S. G., Weinberg, P. D., & Lever, M. J. (2004). Spectroscopic imaging of arteries and atherosclerotic plaques. Biopolymers, 74, 328-335.
6. Ebube, N. K., Hikal, A. H., Wyandt, C. M., Beer, D. C., Miller, L. G., & Jones, A. B. (1997). Effect of drug, formulation and process variables on granulation and compaction characteristics of heterogenous matrices. Part 1: HPMC and HPC systems. Int. J. Pharm., 156, 49-57.
7. Espeau, P., Céolin, R., Tamarit, J. L., Perrin, M. A., Gauchi, J. P., & Leveiller, F. (2005). Polymorphism of paracetamol: Relative stabilities of the monoclinic and orthorhombic phases inferred from topological pressure-temperature and temperature-volume phase diagrams. J. Pharm. Sci., 94, 524-539.
8. Fleming, O. S., Chan, K. L. A., & Kazarian, S. G. (2004). FT-IR imaging and Raman microscopic study of poly(ethylene terephthalate) film processed with supercritical CO2, Vib. Spectrosc., 35, 3-7.
9. Garcia, A. M., & Ghaly, E. S. (1996). Preliminary spherical agglomerates of water soluble drug using natural polymer and cross-linking technique. J. Contr. Release, 40, 179-186.
10. Goldszal, A., & Bousquet, J. (2001). Wet agglomeration of powders: from physics toward process optimization. Powder Tech., 117, 221-231.
11. Habib, M. J., Venkataram, S., & Delwar Hussain, M. (2001). Fundamentals of solid dispersions. In M. J. Habib (Ed.) Pharmaceutical solid dispersion technology (pp. 7-35). Lancaster: Technomic.
12. Hecq, J., Deleers, M., Fanara, D., Vranckx, H., & Amighi, K. (2005). Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int. J. Pharm., 299, 167-177.
13. Iveson, S. M., Lister, J. D., Hapgood, K., & Ennis, B. J. (2001). Nucleation, growth and breakage phenomena in agitated wet granulation processes: A review. Powder Tech., 117, 3-39.
14. Johansen, A., & Schæfer, T. (2001). Effects of interactions between powder particle size and binder viscosity on agglomerate growth mechanisms in a high shear mixer. Eur. J. Pharm. Sci., 12, 297-309.
15. Jørgensen, K., & Christensen, F. N. (1996). Shape modeling of dissolution profiles by non-integer kinetic orders. Int. J. Pharm., 143, 223-232.
16. Keleb, E. I., Vermeire, A., Vervaet C., & Remon, J. P. (2004). Extrusion granulation and high shear granulation of different grades of lactose and high dosed drugs: A comparative study. Drug Dev. Ind. Pharm., 30, 679-691.
17. Kim, S., Lotz, B., Lindrud, M., Girard, K., Moore, T., Nagarajan, K., Alvarez, M., Lee, T., Nikfar, F., Davidovich, M., Srivastava, S., & Kiang, S. (2005). Control of the particle properties of a drug substance by crystallization engineering and the effect on drug product formulation. Org. Proc. Res. Dev., 9, 894-901.
18. Lai, M. K., & Tsiang, R. C. C. (2005). Microencapsulation of acetaminophen into poly(L-lactide) by three different emulsion solvent-evaporation methods. J. Microencap., 22, 261-274.
19. Lee, T. H., & Lin, S. Y. (2004). Microspectroscopic FT-IR mapping system as a tool to assess blend homogeneity of drug excipient mixtures. Eur. J. Pharm. Sci., 23, 117-122.
20. Lee, T., Hung, S. T., & Kuo, C. S. (2006). Polymorph farming of acetaminophen and sulfathiazole on a chip. Pharm. Res., 23, 2542-2555.
21. Lee, T., Kuo, C. S., & Chen, Y. H. (2006). Solubility, polymorphism, crystallinity, and crystal habit of acetaminophen and ibuprofen by initial solvent screening. Pharm. Tech., 30, 72-92.
22. Leuenberger, H. & Lanz, M. (2005). Pharmaceutical powder technology - from art to science; the challenge of the FDA's process analytical technology initiative. Adv. Powder Tech., 16, 3-25.
23. Oyewo, M. N. F., & Spring, M. S. (1994). Studies on paracetamol crystals produced by growth in aqueous solution. Int. J. Pharm., 112, 17-28.
24. Pepin, X., Blanchon, S., & Couarraze, G. (2001). Power consumption profiles in high-shear wet granulation. I: Liquid distribution in relation to powder and binder properties. J. Pharm. Sci., 90, 322-331.
25. Petibois, C., & Déléris, G. (2006). Chemical mapping of tumor progression by FT-IR imaging: Towards molecular histopathology. Trends Biotechnol., 24, 455-462.
26. Railkar, A. M., & Schwartz, J. B. (2001) Use of a moist granulation technique (MGT) to develop controlled-release dosage forms of acetaminophen. Drug Dev. Ind. Pharm., 27, 337-343.
27. Rough, S. L., Wilson, D. I., & York, D. W. (2005). Effect of solids formulation on the manufacture of high shear mixer agglomerates. Adv. Powder Technol., 16, 145-169.
28. Schæfer, T. (2001). Growth mechanisms in melt agglomeration in high shear mixers. Powder Tech., 117, 68-82.
29. Sorasuchart, W., Wardrop, J., & Ayres, J. W. (1999). Drug release from spray layered and coated drug-containing beads: effects of pH and comparison of different dissolution methods. Drug Dev. Ind. Pharm., 25, 1093-1098.
30. Timmins, P., Delargy, A. M., Minchom, C. M., & Howard, J. R. (1992). Influence of some process variables on product properties for a hydrophilic matrix controlled release tablet. Eur. J. Pharm. Biopharm., 38, 113-118.
31. van den Dries, K., de Vegt, O. M., Girard, V., & Vromans, H. (2003). Granule breakage phenomena in a high shear mixer; influence of process and formulation variables, and consequences on granule homogeneity. Powder Tech., 133, 228-236.
32. van den Dries, K., & Vromans, H. (2002). Relationship between inhomogeneity phenomena and granule growth mechanisms in a high shear mixer. Int. J. Pharm., 247, 167-177.
33. van den Dries, K., & Vromans, H. (2003). Experimental and modelistic approach to explain granulate inhomogeneity through preferential growth. Eur. J. Pharm. Sci., 20, 409-417.
34. Vonk, P., Guillaume, C. P. F., Ramaker, J. S., Vromans, H., & Kossen, N. W. F. (1997). Growth mechanisms of high-shear pelletization. Int. J. Pharm., 157, 93-102.
35. Wade, A., & Weller, P. J. (1994). Handbook of pharmaceutical excipients. 2nd ed. Washington: American Pharmaceutical Association, pp. 392-399.